{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:46:03Z","timestamp":1774953963584,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neurofibromatosis type I (NF1) is a genetic disorder characterized by the tumor\u2019s development in nerve tissue. Complications of NF1 can include pigmented lesions, skin neurofibromas, and heart problems such as cardiomyopathy. In this study, we performed whole-exome sequencing (WES) on an Iranian patient with NF1 to identify the genetic cause of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Following clinical assessment, WES was used to identify genetic variants in a family with a son suffering from NF1. No symptomatic manifestations were observed in other family members. In the studied family, <jats:italic>in silico<\/jats:italic> and segregation analysis were applied to survey candidate variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Clinical manifestations were consistent with arrhythmogenic cardiomyopathy (ACM). WES detected a likely pathogenic heterozygous missense variant, c.3277G\u2009&gt;\u2009A:p.Val1093Met, in the <jats:italic>NF1<\/jats:italic> gene, confirmed by PCR and Sanger sequencing. The patient\u2019s parents and brother had a normal sequence at this locus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although there is no cure for NF1, genetic tests, such as WES, can detect at-risk asymptomatic family members. Furthermore, cardiac evaluation could also help these patients before heart disease development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03878-z","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T07:01:36Z","timestamp":1713855696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Maryam","family":"Pourirahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Abdolkarimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Kalayinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"3878_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.pathol.2.010506.091940","volume":"2","author":"AI McClatchey","year":"2007","unstructured":"McClatchey AI, Neurofibromatosis. Annu Rev Pathol Mech Dis. 2007;2:191\u2013216.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"3","key":"3878_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/2047-783X-14-3-102","volume":"14","author":"P Gerber","year":"2009","unstructured":"Gerber P, Antal A, Neumann N, Homey B, Matuschek C, Peiper M, et al. Neurofibromatosis Eur J Med Res. 2009;14(3):102\u20135.","journal-title":"Neurofibromatosis Eur J Med Res"},{"key":"3878_CR3","doi-asserted-by":"crossref","unstructured":"Korf BR. Neurofibromatosis. Handbook of clinical neurology. 2013;111:333\u2009\u2013\u200940.","DOI":"10.1016\/B978-0-444-52891-9.00039-7"},{"issue":"1","key":"3878_CR4","first-page":"1","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Reviews Disease Primers. 2017;3(1):1\u201317.","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"3878_CR5","first-page":"105","volume":"4","author":"J Friedman","year":"2002","unstructured":"Friedman J, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Sci. 2002;4(3):105\u201311.","journal-title":"Genet Sci"},{"issue":"8","key":"3878_CR6","first-page":"714","volume":"43","author":"F \u0130ncecik","year":"2015","unstructured":"\u0130ncecik F, Herg\u00fcner \u00d6M, Al\u0131n\u00e7 Erdem S, Altunba\u015fak \u015e. Neurofibromatosis type 1 and cardiac manifestations. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir. 2015;43(8):714\u20136.","journal-title":"Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir"},{"key":"3878_CR7","doi-asserted-by":"crossref","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR et al. Health supervision for children with neurofibromatosis type 1. Pediatrics. 2019;143(5).","DOI":"10.1542\/peds.2019-0660"},{"issue":"3","key":"3878_CR8","doi-asserted-by":"publisher","first-page":"omz021","DOI":"10.1093\/omcr\/omz021","volume":"2019","author":"M Ibarrola","year":"2019","unstructured":"Ibarrola M, P\u00e9rez-Riera AR, Gonz\u00e1lez MD. Left ventricular noncompaction and orthodromic atrioventricular tachycardia observed in a patient with neurofibromatosis type 1. Oxf Med Case Rep. 2019;2019(3):omz021.","journal-title":"Oxf Med Case Rep"},{"issue":"8","key":"3878_CR9","first-page":"935","volume":"31","author":"A Jurko Jr","year":"2010","unstructured":"Jurko A Jr, Minarik M, Minarikova E, Nagi AS. Neurofibromatosis associated with hypertrophic cardiomyopathy. Saudi Med J. 2010;31(8):935\u20136.","journal-title":"Saudi Med J"},{"issue":"4","key":"3878_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cge.12072","volume":"84","author":"R Nguyen","year":"2013","unstructured":"Nguyen R, Mir T, Kluwe L, Jett K, Kentsch M, Mueller G, et al. Cardiac characterization of 16 patients with large NF1 gene deletions. Clin Genet. 2013;84(4):344\u20139.","journal-title":"Clin Genet"},{"issue":"16","key":"3878_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"9","key":"3878_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"16","key":"3878_CR13","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164\u2013e.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3878_CR14","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Sci. 2015;17(5):405\u201323.","journal-title":"Genet Sci"},{"issue":"1","key":"3878_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123(1):124\u201333.","journal-title":"Pediatrics"},{"issue":"2","key":"3878_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/archdischild-2014-308084","volume":"101","author":"B Dunning-Davies","year":"2016","unstructured":"Dunning-Davies B, Parker A. Annual review of children with neurofibromatosis type 1. Archives Disease Childhood-Education Pract. 2016;101(2):102\u201311.","journal-title":"Archives Disease Childhood-Education Pract"},{"issue":"6","key":"3878_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ajmg.a.61123","volume":"179","author":"A Ritter","year":"2019","unstructured":"Ritter A, Cuddapah S, Degenhardt K, Kasperski S, Johnson MP, O\u2019Connor MJ, et al. Fetal cardiomyopathy in neurofibromatosis type I: novel phenotype and review of the literature. Am J Med Genet Part A. 2019;179(6):1042\u20136.","journal-title":"Am J Med Genet Part A"},{"key":"3878_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-6-12","volume":"6","author":"A Alkindy","year":"2012","unstructured":"Alkindy A, Chuzhanova N, Kini U, Cooper DN, Upadhyaya M. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Hum Genomics. 2012;6:1\u20137.","journal-title":"Hum Genomics"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03878-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03878-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03878-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T07:02:44Z","timestamp":1713855764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03878-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3878"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03878-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"25 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran (IR.RHC.REC.1402.017). Written informed consent was obtained from the participant family.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent for publication was obtained from all the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"220"}}